Risk of death or hospitalisation according to age group and health condition for children younger than 18 years of age with COVID-19 from 7 March 2020 to 30 September 2021 in Mexico
| Age group | OR | Fisher’s exact test P value | 95% CI |
| Risk of death by age group | |||
| <1 year (n: 5703) | 16.67 | 0.000 | 14.13 to 19.66 |
| 1–5 years (n: 24 067) | 3.34 | 0.000 | 2.82 to 3.96 |
| 6–9 years (n: 28 764) | 1.07 | 0.055 | 0.84 to 1.36 |
| 10–17 years (n: 132 195) | 1 | – | – |
| Risk of hospitalisation by age | |||
| <1 year (n: 5703) | 20.11 | 0.000 | 18.87 to 21.43 |
| 1–5 years (n: 24 067) | 3.77 | 0.000 | 3.57 to 3.98 |
| 6–9 years (n: 28 764) | 1.43 | 0.000 | 1.34 to 1.54 |
| 10–17 years (n: 132 195) | 1 | – | – |
| Risk of death or hospitalisation by age group according to health condition | ||||||||
| <1 year | 1–5 years | 6–9 years | 10–17 years | |||||
| Condition | Hospitalised | Deceased | Hospitalised | Deceased | Hospitalised | Deceased | Hospitalised | Deceased |
| Male | 1.16 (1.0–1.3) | – | 1.28 (1.1–1.3) | – | 1.25 (1.1–1.4) | – | – | – |
| Pneumonia | 29.70 (23.1–38.1) | 99.72 (69.6–142.8) | 51.12 (43.3–60.2) | 227.81 (164.7–314.9) | 51.84 (42.9–62.5) | 228.79 (142.2–368.1) | 65.45 (59.6–71.7) | 280.40 (220.4–356.7) |
| Indigenous | – | – | 3.84 (2.8–5.1) | – | 2.61 (1.6–4.2) | – | 3.49 (2.8–4.3) | 2.52 (1.12–5.67) |
| Immunosuppression | 5.34 (3.2–8.7) | 7.02 (3.1–15.5) | 25.15 (18.5–34.0) | 28.43 (15.8–50.9) | 42.25 (31.7–56.2) | 77.61 (42.5–141.6) | 42.99 (35.9–51.4) | 72.23 (50.5–103.2) |
| Other comorbidity | 5.41 (3.9–7.4) | 8.20 (4.95–13.6) | 16.04 (13.3–19.3) | 35.51 (25.1–50.1) | 19.13 (15.1–24.1) | 55.73 (33.4–92.9) | 16.01 (14.0–18.2) | 32.90 (24.7–43.6) |
| Chronic kidney disease | – | 4.80 (1.31–17.5) | 4.99 (2.5–9.7) | 12.86 (3.8–42.9) | 6.31 (2.9–13.7) | 22.13 (5.2–93.9) | 21.60 (16.9–27.4) | 63.87 (42.2–96.5) |
| Cardiovascular disease | 4.44 (2.87–6.88) | 13.85 (7.8–24.3) | 14.60 (10.5–20.1) | 32.4 (18.8–55.8) | 5.38 (3.0–9.6) | 10.72 (2.5–44.5) | 7.33 (5.6–9.5) | 19.26 (11.5–32.2) |
| High blood pressure | – | 4.81 (3.1–7.3) | 5.27 (3.1–8.7) | 11.57 (4.9–27.1) | 2.73 (1.0–6.8) | 14.42 (3.4–60.3) | 7.83 (6.0–10.0) | 10.10 (5.5–18.5) |
| Obesity | – | – | – | – | 2.11 (1.5–2.9) | 5.39 (2.4–11.7) | 3.24 (2.9–3.6) | 5.18 (3.8–6.9) |
| Diabetes | – | 4.41 (2.6–7.3) | 4.92 (2.9–8.2) | 7.47 (2.2–24.2) | 3.42 (1.6–7.1) | – | 9.40 (7.6–11.4) | 16.75 (10.5–26.5) |
| COPD | 3.60 (1.35–9.61) | – | 11.97 (3.2–44.6) | – | – | – | – | 8.32 (2.0–33.9) |
| Asthma | – | – | 1.99 (1.4–2.6) | – | 1.92 (1.4–2.5) | – | 1.42 (1.1–1.6) | – |
| 1–2 comorbidities | 5.34 (4.6–6.0) | 41.30 (22.3–76.4) | 16.17 (14.5–17.9) | 74.39 (51.71–107.0) | 11.41 (10.0–12.9) | 40.48 (23.3–70.0) | 10.66 (9.9–11.4) | 51.28 (37.2–70.5) |
| 3–4 comorbidities | 5.73 (3.7–8.7) | 41.30 (22.3–76.4) | 59.15 (36.5–95.6) | 354.47 (168.5–745.6) | 58.14 (33.9–99.7) | 628.92 (261.4–1512.7) | 99.40 (79.2–124.6) | 848.1 (543.0–1324.6) |
Source: Mexican Ministry of Health.29
n=total number of cases in the category.
Includes risks with statistical significance.
COPD, chronic obstructive pulmonary disease.;